136 related articles for article (PubMed ID: 1976291)
1. Structural characteristics of compounds that modulate P-glycoprotein-associated multidrug resistance.
Pearce HL; Winter MA; Beck WT
Adv Enzyme Regul; 1990; 30():357-73. PubMed ID: 1976291
[TBL] [Abstract][Full Text] [Related]
2. Essential features of the P-glycoprotein pharmacophore as defined by a series of reserpine analogs that modulate multidrug resistance.
Pearce HL; Safa AR; Bach NJ; Winter MA; Cirtain MC; Beck WT
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):5128-32. PubMed ID: 2567994
[TBL] [Abstract][Full Text] [Related]
3. Effects of indole alkaloids on multidrug resistance and labeling of P-glycoprotein by a photoaffinity analog of vinblastine.
Beck WT; Cirtain MC; Glover CJ; Felsted RL; Safa AR
Biochem Biophys Res Commun; 1988 Jun; 153(3):959-66. PubMed ID: 2898941
[TBL] [Abstract][Full Text] [Related]
4. A structure-function relationship among reserpine and yohimbine analogues in their ability to increase expression of mdr1 and P-glycoprotein in a human colon carcinoma cell line.
Bhat UG; Winter MA; Pearce HL; Beck WT
Mol Pharmacol; 1995 Oct; 48(4):682-9. PubMed ID: 7476894
[TBL] [Abstract][Full Text] [Related]
5. N-(p-azido-3-[125I]iodophenethyl)spiperone binds to specific regions of P-glycoprotein and another multidrug binding protein, spiperophilin, in human neuroblastoma cells.
Safa AR; Agresti M; Bryk D; Tamai I
Biochemistry; 1994 Jan; 33(1):256-65. PubMed ID: 7904476
[TBL] [Abstract][Full Text] [Related]
6. Effects of isoquinolinesulphonamide compounds on multidrug-resistant P388 cells.
Nakamura S; Wakusawa S; Tajima K; Miyamoto K; Hagiwara M; Hidaka H
J Pharm Pharmacol; 1993 Apr; 45(4):268-73. PubMed ID: 8098366
[TBL] [Abstract][Full Text] [Related]
7. Human (MDR1) and mouse (mdr1, mdr3) P-glycoproteins can be distinguished by their respective drug resistance profiles and sensitivity to modulators.
Tang-Wai DF; Kajiji S; DiCapua F; de Graaf D; Roninson IB; Gros P
Biochemistry; 1995 Jan; 34(1):32-9. PubMed ID: 7819214
[TBL] [Abstract][Full Text] [Related]
8. Sensitization of multidrug resistant (MDR) cancer cells to vinblastine by novel acridones: correlation between anti-calmodulin activity and anti-MDR activity.
Mayur YC; Padma T; Parimala BH; Chandramouli KH; Jagadeesh S; Gowda NM; Thimmaiah KN
Med Chem; 2006 Jan; 2(1):63-77. PubMed ID: 16787357
[TBL] [Abstract][Full Text] [Related]
9. Multidrug resistance after retroviral transfer of the human MDR1 gene correlates with P-glycoprotein density in the plasma membrane and is not affected by cytotoxic selection.
Choi K; Frommel TO; Stern RK; Perez CF; Kriegler M; Tsuruo T; Roninson IB
Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7386-90. PubMed ID: 1678523
[TBL] [Abstract][Full Text] [Related]
10. Modulators of the multidrug-transporter, P-glycoprotein, exist in the human plasma.
Ichikawa M; Yoshimura A; Furukawa T; Sumizawa T; Akiyama S
Biochem Biophys Res Commun; 1990 Jan; 166(1):74-80. PubMed ID: 1967939
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein as multidrug transporter: a critical review of current multidrug resistant cell lines.
Nielsen D; Skovsgaard T
Biochim Biophys Acta; 1992 Jul; 1139(3):169-83. PubMed ID: 1352705
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and chemical characterization of 2-methoxy-N(10)-substituted acridones needed to reverse vinblastine resistance in multidrug resistant (MDR) cancer cells.
Krishnegowda G; Thimmaiah P; Hegde R; Dass C; Houghton PJ; Thimmaiah KN
Bioorg Med Chem; 2002 Jul; 10(7):2367-80. PubMed ID: 11983534
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the spacer in N,N-bis(alkanol)amine aryl ester heterodimers led to the discovery of a series of highly potent P-glycoprotein-based multidrug resistance (MDR) modulators.
Dei S; Braconi L; Trezza A; Menicatti M; Contino M; Coronnello M; Chiaramonte N; Manetti D; Perrone MG; Romanelli MN; Udomtanakunchai C; Colabufo NA; Bartolucci G; Spiga O; Salerno M; Teodori E
Eur J Med Chem; 2019 Jun; 172():71-94. PubMed ID: 30947123
[TBL] [Abstract][Full Text] [Related]
14. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
15. Rational design and pre-clinical pharmacology of drugs for reversing multidrug resistance.
Hait WN; Aftab DT
Biochem Pharmacol; 1992 Jan; 43(1):103-7. PubMed ID: 1346493
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of P-glycoprotein-mediated vinblastine transport across HCT-8 intestinal carcinoma monolayers by verapamil, cyclosporine A and SDZ PSC 833 in dependence on extracellular pH.
Zacherl J; Hamilton G; Thalhammer T; Riegler M; Cosentini EP; Ellinger A; Bischof G; Schweitzer M; Teleky B; Koperna T
Cancer Chemother Pharmacol; 1994; 34(2):125-32. PubMed ID: 7910786
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic circumvention of multidrug resistance.
Ford JM; Hait WN
Cytotechnology; 1993; 12(1-3):171-212. PubMed ID: 7765325
[TBL] [Abstract][Full Text] [Related]
18. Effect of modulators on the ATPase activity and vanadate nucleotide trapping of human P-glycoprotein.
Shepard RL; Winter MA; Hsaio SC; Pearce HL; Beck WT; Dantzig AH
Biochem Pharmacol; 1998 Sep; 56(6):719-27. PubMed ID: 9751076
[TBL] [Abstract][Full Text] [Related]
19. The nitrogen of the acetamido group of colchicine modulates P-glycoprotein-mediated multidrug resistance.
Tang-Wai DF; Brossi A; Arnold LD; Gros P
Biochemistry; 1993 Jun; 32(25):6470-6. PubMed ID: 8100149
[TBL] [Abstract][Full Text] [Related]
20. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR).
Teodori E; Dei S; Martelli C; Scapecchi S
Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
